# GLP-1 Discounts vs Seller Disclosure: Dose Ladders and State Lists | This GLP Do GLP-1 sellers using first-month rates, codes or struck-through prices disclose less? Compared on dose ladders, higher-dose pricing and state lists, the answer runs the other way. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/research/do-discounting-sellers-disclose-less Updated: 2026-10-26 Published: 2026-09-16 [← Research](https://thisglp.com/research) Formats # GLP-1 Discounts vs Seller Disclosure: Dose Ladders and State Lists A page covered in struck-through prices reads as less trustworthy than a plain one. Discounting GLP-1 sellers publish a dose ladder more often, not less, and the reason is structural. [This GLP Editorial Team](https://thisglp.com/about)September 20265 min readUpdated September 2026 solid = uses promotional wording · pale = does not · publishes a dose ladder · 80% · 28% · states what the price does at a higher dose · 43% · 35% · publishes a list of states · 47% · 32% · The top pair runs the opposite way from the intuition. **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms). ## Key takeaways - 99 rankable sellers use promotional wording in their recorded pricing; 481 do not. - Sellers who discount publish a dose ladder more often, not less: 80% against 28%. - On stating what the price does at a higher dose the two groups are level: 43% against 35%. - On publishing a state list they are close: 47% against 32%. - The intuition that a hard-selling page tells you less does not hold on this roster. A page covered in struck-through prices and first-month offers reads as less trustworthy than a plain one, and it is natural to expect that it also tells you less. That expectation is testable, and on this roster it is wrong — as wrong as the assumption tested in [is disclosure a trait](https://thisglp.com/research/is-seller-disclosure-a-trait), and in a more interesting direction. ## What the comparison shows 99 of the sellers this site can rank use promotional language somewhere in their recorded pricing — a first month, an introductory rate, a code, a struck-through anchor. The other 481 do not. On the hardest disclosure in this category, publishing a dose ladder, the promotional group does better: 80% against 28%. On stating what the price does at a higher dose the two are level at 43% and 35%, and on publishing a state list they sit at 47% and 32%. The boring explanation, before the interesting one ⛔ The likeliest reason is not that discounting makes a seller candid. It is that a page showing many figures has many figures to discount. A seller publishing a five-rung ladder has five prices to put a strike-through against; a seller publishing one starting price has one. Both behaviors follow from the same underlying thing — a page that shows a lot of numbers — which means this is a correlation with an obvious confounder rather than a finding about character. ## What it does not excuse Anything. A promotional figure is still not a standing rate, a struck-through anchor is still a number nobody has been charged, and a fifth of the pricing notes on this roster are offers rather than prices — which is the separate count in [how much of this pricing is a promotion](https://thisglp.com/research/how-much-glp1-pricing-is-promotional). What changes is the inference a reader draws from the style of a page. Marketing intensity is not a proxy for opacity here, so a plain-looking storefront has not thereby earned anything, and a loud one has not forfeited it. ## Where this sits beside the other cross-check This site has run one other test of whether a seller’s behavior predicts its behavior elsewhere, in [is disclosure a trait](https://thisglp.com/research/is-seller-disclosure-a-trait), and found nothing at all: publishing a ladder said nothing about publishing a state list. The two results fit together. Disclosure does not travel between dimensions, and the one association that does appear has a structural cause rather than a moral one. The practical conclusion is the same as it was: check the specific thing you care about, seller by seller, as listed in [the questions they leave open](https://thisglp.com/tools/questions-they-leave-open). Corpus read October 2026. [Science & Co](https://thisglp.com/reviews/science-and-co) identifies its lowest advertised rate as a twelve-month-plan figure in its [FAQ](https://science.co/faq). That qualification is a disclosure worth preserving beside the price. Whether a discount exists and whether its commitment is clearly explained are separate questions, just as the aggregate comparison above suggests. ## Frequently asked Do promotional sellers disclose less? Not on this roster. They publish a dose ladder more often than sellers using no promotional wording, and the two groups are level on stating dose behavior and on publishing a state list. Does that mean discounting is a good sign? No. The likeliest explanation is structural: a page showing many figures has many figures to discount, so both behaviors follow from the same cause. Does it change anything about promotional pricing? Nothing. A promotional figure is still not a standing rate and an anchor is still a number nobody has been charged. What changes is only what a reader should infer from the style of a page. ## Sources ## Where to get it ### Best GLP-1 injections Every injectable seller we can verify, with the price each one publishes and an honest read of what the trials measured. [Compare providers →](https://thisglp.com/best/compounded-semaglutide) ## More in Formats - [ Label-approved sites and semaglutide exposure · Abdomen · 2 in. from navel · similar · Thigh · under the skin · similar · Upper arm · under the skin · similar · Blood levels, not weight loss. No trial randomized people to a site. ### Where Should You Inject Ozempic? Abdomen, Thigh or Arm Gave the Same Exposure ](https://thisglp.com/research/where-should-you-inject-ozempic) - [ The labeled ladder — four weeks on every rung · 0.25 · wk 1–4 · 0.5 · wk 5–8 · 1 · wk 9–12 · 1.7 · wk 13–16 · 2.4 · wk 17+ · Milligrams weekly. No compounded product carries this label. ### Semaglutide Starting Dose: 0.25 mg, and What Compounding Changes ](https://thisglp.com/research/semaglutide-starting-dose) - [ Approved: weight management, US, April 2026 · Phase 3 in progress, not approved: · sleep apnea · hypertension · urinary incontinence · osteoarthritis pain · artery disease · A daily tablet, not a peptide, not an injection. ### Is There a GLP-1 Pill That Works? Two Tablets, Two Different Answers ](https://thisglp.com/research/does-the-glp1-pill-work-as-well-as-the-injection)